By contrast, large clones from MM patients were enriched in CD8+ GZMK+ PRF1+ (p < 0.01), CD8+ effector GZMK+ (p < 0.05) and CD8+ TOX+ (p < 0.01) T cells. This evidence concerns the gene GZMK and Miyoshi myopathy.